ASBP is trading 6.9% down at $6.01 as the stock extends a pullback following its recent Amazon launch and ahead of a planned presentation at the Life Sciences Investor Forum.
- Traders are unwinding portions of the prior rally, with the decline primarily driven by company-specific profit-taking and a reassessment of recent news.
- The move comes as the broader market remains relatively flat, suggesting the price action is independent of macro factors.